Seacor Holdings Inc. (CKH) Forms $47.74 Double Top; Redmile Group Increased Its Atara Biotherapeutics (ATRA) Stake

January 3, 2018 - By Martha Paddon

Redmile Group Llc increased Atara Biotherapeutics Inc (ATRA) stake by 5.69% reported in 2017Q3 SEC filing. Redmile Group Llc acquired 155,666 shares as Atara Biotherapeutics Inc (ATRA)’s stock declined 2.88%. The Redmile Group Llc holds 2.89 million shares with $47.83 million value, up from 2.73M last quarter. Atara Biotherapeutics Inc now has $553.79M valuation. It closed at $18.1 lastly. It is up 7.28% since January 3, 2017 and is downtrending. It has underperformed by 23.98% the S&P500.

Seacor Holdings Inc. (CKH) formed double top with $49.17 target or 3.00% above today’s $47.74 share price. Seacor Holdings Inc. (CKH) has $852.60 million valuation. The stock increased 3.29% or $1.52 during the last trading session, reaching $47.74. About 83,110 shares traded. Seacor Holdings Inc. (NYSE:CKH) has risen 18.91% since January 3, 2017 and is uptrending. It has outperformed by 2.21% the S&P500.

Analysts await Seacor Holdings Inc. (NYSE:CKH) to report earnings on March, 27. They expect $0.32 EPS, up 105.80% or $5.84 from last year’s $-5.52 per share. CKH’s profit will be $5.71M for 37.30 P/E if the $0.32 EPS becomes a reality. After $0.38 actual EPS reported by Seacor Holdings Inc. for the previous quarter, Wall Street now forecasts -15.79% negative EPS growth.

Among 2 analysts covering Seacor Holdings (NYSE:CKH), 0 have Buy rating, 0 Sell and 2 Hold. Therefore 0 are positive. Seacor Holdings has $75 highest and $3700 lowest target. $41.50’s average target is -13.07% below currents $47.74 stock price. Seacor Holdings had 7 analyst reports since August 24, 2016 according to SRatingsIntel. On Tuesday, June 27 the stock rating was maintained by Stifel Nicolaus with “Buy”. The rating was maintained by Stifel Nicolaus with “Buy” on Thursday, September 7. On Monday, August 7 the stock rating was maintained by Stifel Nicolaus with “Buy”. Credit Suisse maintained the shares of CKH in report on Friday, November 3 with “Neutral” rating. Stifel Nicolaus downgraded the stock to “Hold” rating in Monday, November 6 report. The company was initiated on Wednesday, August 24 by Stifel Nicolaus.

Investors sentiment increased to 1.04 in Q3 2017. Its up 0.33, from 0.71 in 2017Q2. It improved, as 26 investors sold Seacor Holdings Inc. shares while 26 reduced holdings. 19 funds opened positions while 35 raised stakes. 33.76 million shares or 9.16% less from 37.16 million shares in 2017Q2 were reported. Robotti Robert invested 1.08% of its portfolio in Seacor Holdings Inc. (NYSE:CKH). First Mercantile Tru Commerce stated it has 4,898 shares. Nationwide Fund holds 0% or 12,605 shares. Bank Of America De holds 126,916 shares or 0% of its portfolio. Tiaa Cref Invest Management Llc has invested 0% in Seacor Holdings Inc. (NYSE:CKH). Metropolitan Life Insurance Co New York owns 11,336 shares or 0% of their US portfolio. Us Bank & Trust De reported 0% stake. Zurcher Kantonalbank (Zurich Cantonalbank) reported 497 shares. Kbc Grp Inc Inc Nv accumulated 8,475 shares. Mason Street Advsr Limited Liability Company accumulated 0% or 4,212 shares. First Eagle Inv Management stated it has 0.01% in Seacor Holdings Inc. (NYSE:CKH). Tower Rech Limited Liability Corp (Trc) owns 2,405 shares for 0.01% of their portfolio. Swiss Fincl Bank has 27,400 shares for 0% of their portfolio. Sg Americas Secs Ltd Liability Corp, New York-based fund reported 2,406 shares. Ameriprise Financial Incorporated reported 90,171 shares.

Since September 14, 2017, it had 0 insider purchases, and 1 sale for $22,214 activity. Shares for $22,214 were sold by LONG WILLIAM C on Thursday, September 14.

Since August 10, 2017, it had 0 buys, and 14 selling transactions for $999,963 activity. $112,159 worth of stock was sold by Haqq Christopher on Tuesday, August 15. The insider Ciechanover Isaac E. sold $64,438. $16,931 worth of stock was sold by Gallagher Carol Giltner on Tuesday, August 15. The insider Clark Mitchall G. sold $43,291. Soffer Gad sold 9,464 shares worth $140,802. MCGRATH JOHN also sold $60,102 worth of Atara Biotherapeutics, Inc. (NASDAQ:ATRA) shares.

Among 6 analysts covering Atara Biotherapeutics (NASDAQ:ATRA), 4 have Buy rating, 1 Sell and 1 Hold. Therefore 67% are positive. Atara Biotherapeutics had 17 analyst reports since September 9, 2015 according to SRatingsIntel. The rating was downgraded by Citigroup on Tuesday, December 15 to “Sell”. The rating was initiated by Canaccord Genuity on Wednesday, September 9 with “Buy”. Jefferies reinitiated it with “Buy” rating and $3000 target in Thursday, June 22 report. The company was maintained on Friday, August 19 by Citigroup. Citigroup maintained the shares of ATRA in report on Monday, August 22 with “Sell” rating. The stock of Atara Biotherapeutics, Inc. (NASDAQ:ATRA) earned “Mkt Perform” rating by JMP Securities on Friday, September 25. The stock of Atara Biotherapeutics, Inc. (NASDAQ:ATRA) has “Buy” rating given on Thursday, August 31 by Jefferies. The company was maintained on Wednesday, March 9 by JMP Securities. JMP Securities maintained the shares of ATRA in report on Tuesday, December 15 with “Market Outperform” rating. The firm has “Buy” rating given on Monday, October 24 by Jefferies.